Some of our research projects

 

  MIMY

  EMpowerment through liquid Integration of Migrant Youth in vulnerable conditions

 

 
Prof. Dr. Birte Nienaber

 

Goals

12 multinational partners aim to improve the situation of young migrants in vulnerable conditions throughout Europe by examining the effectiveness of integration policies in an interdisciplinary research endeavor.

Method

MIMY applies a comprehensive mixed-methods approach combining various quantitative and qualitative methods on different levels of analysis. Additionally, the project actively engages young migrants to include their voice within migration research, mainly through the involvement of peer researchers.

Implementation

The project will examine processes of integration of young non-EU migrant in 18 local contexts, 2 in each of the 9 European countries involved. Each case study represents a specific local context, but may also target a specific representative subgroup.

Where

The action is covering 2 case studies each in Luxembourg, Germany, United Kingdom, Sweden, Norway, Italy, Poland, Romania, and Hungary while benefiting from the support of the European Confederation of Youth Clubs.

Uni.lu role

Uni.lu coordinates (including project management and scientific coordination) the MIMY project, leads the participatory action research activities and conducts the case studies in Luxembourg.

Success stories and updates

Position Pager 24/07/2020

EU

The project has received funding from the European Union’s Horizon 2020 research and innovation programme under the grant agreement No 870700.

 
Faculty of Humanities, Education and Social Sciences

 

 
Department of Geography and Spatial Planning
Department of Behavioural and Cognitive Sciences

 

 
www.mimy-project.eu

 

 
H2020 – Societal Challenges
€ 2 999 998,75

 

 
01/02/2020-31/01/2023

 

  • Institut Für Landes- Und Stadtentwicklungsforschung
  • Hawk Hochschule Für Angewandte Wissenschaft Und Kunst Fachhochschule Hildesheim/ Holzminden/ Göttingen
  • Universitetet I Bergen
  • Academia De Studii Economice Din Bucuresti
  • Malmö Universitet
  • Università Cattolica Del Sacro Cuore
  • The University Of Sheffield
  • Kozep-Europai Egyetem
  • Swps Uniwersytet Humanistycznos-poleczny
  • Eurice European Research And Project Office
  • Europese Confederatie Van Organisaties Voor Jeugdcentra Ecyc Vereniging

 

Working Yet Poor

 

  WorkYP

  Working, Yet Poor

 
Prof. Dr. Luca Ratti

 

Goals

WorkYP aims to investigate on the increasing social trend of working people at risk or below the poverty line in view of attenuating divergent trends across Europe. Such attenuation would effectively prevent the risk of social dumping and reduce economic shocks.

Method

Comparative and multi-disciplinary perspectives are applied when analyzing four pre-identified clusters of particularly vulnerable and underrepresented persons (VUPs) which disadvantaged conditions impede full enjoyment of EU citizenship.

Implementation

The WorkYP Consortium plans to elaborate the necessary theoretical frameworks, initiate public debates, provide policy recommendations and practical tools to deliver a sound and easily understandable concept of EU social citizenship.

Where

The action is covering case studies in seven countries (Sweden, Italy, The Netherlands, Belgium, Luxembourg, Germany, and Poland) selected on the basis of their geographical location, social system and legal order. At the same time, the project is supported by three Social Rights Institutions.

Uni.lu role

Uni.lu coordinates (including project management and ethics) the WorkYP project, leads the investigatory activities of economists and sociologists of all academic partners and runs the societal impact assessment which aims to identify best practices for tackling in-work poverty.

Success stories and updates

Article "In-work poverty in times of pandemic"

EU

The project has received funding from the European Union’s Horizon 2020 research and innovation programme under the grant agreement No 870619.

 
Faculty of Law, Economics and Finance
Faculty of Humanities, Education and Social Sciences

 

 
Department of Law
Department of Behavioural and Cognitive Sciences

 

 
workingyetpoor.eu

 

 
H2020 – Societal Challenges
€ 3 250 206,25

 

 
01/02/2020-31/01/2023

 

  • University of Bologna
  • Goethe University of Frankfurt
  • KULeuven
  • Tilburg University
  • Erasmus University Rotterdam
  • University of Lund
  • University of Gdansk
  • Observatoire Social Européenne
  • Fondazione Giacomo Brodolini
  • European Anti-Poverty Network

 

imSAVAR

 

  imSAVAR
  Immune Safety Avatar: nonclinical mimicking of the immune system effects of 
  immunomodulatory therapies

 
Prof. Dr. Reinhard Schneider

 

Goals

The project aims to improve the ability to predict adverse immune-related toxicities and establish a standard approach to immune safety.

Method

By developing a platform that consists of processes for developing nonclinical assessment strategies as well as models that represent the complexity of diseases and predict the immune related adverse events, imSAVAR improves the prediction of the transferability of safety and efficacy of immunomodulators from pre-clinical models to first-in-human studies.

Implementation

The imSAVAR platform is based upon in vitro and in vivo case studies for prioritized therapeutic modalities while considering also the input of multiple stakeholders, including regulatory agencies.

Where

The action is covering case studies in seven countries (Sweden, Italy, The Netherlands, Belgium, Luxembourg, Germany, and Poland) selected on the basis of their geographical location, social system and legal order. At the same time, the project is supported by three Social Rights Institutions.

Uni.lu role

Uni.lu is co-leading the development and deployment of the data and knowledge platform (i.e. data management plan, link to sample management system, data harmonization) and contributes to the biomarker (molecular profiling) development of immune cells.

Success stories and updates

Stakeholder Workshop

EU

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 853988. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and JDRF INTERNATIONAL.

 
Luxembourg Centre for Systems Biomedicine

 

 
Bioinformatics Core Research Unit

 

 
imsavar.eu

 

 
H2020 – Innovative Medicine Initiative
€ 10 999 316,25

 

 
01/12/2019 – 30/11/2025

 

  • Fraunhofer
  • Forschung E.V.
  • Universitaetsklinikum Jena
  • Universiteit Twente
  • Biosci Consulting Bvba
  • Academisch Ziekenhuis Leiden
  • Universitaet Leipzig
  • Medizinische Hochschule Hannover
  • Eberhard Karls Universitaet Tuebingen
  • Medizinische Universitaet Innsbruck
  • Bundesinst. fuer Impfstoffe und Biomed. Arzneimittel
  • IT For Translational Medicine SA
  • Universitaetsklinikum Wuerzburg
  • Julius-Maximilians-Universitaet
  • Lunds Universitet
  • T-Curx Gmbh
  • Universitetet I Oslo
  • Dynamic42 GmbH
  • Bluebird Bio Inc.
  • Covance Laboratories Ltd
  • Boehringer Ingelheim International GmbH
  • Jdrf International
  • Merck Kommanditgesellschaft auf Aktien
  • Novartis Pharma AG
  • F. Hoffmann-La Roche AG
  • Sanofi-Aventis R&D
  • Institut De Recherches Servier
  • Transgene SA
  • Merck Sharp & Dohme Corp

 

immUniverse

 

  ImmUniverse
  Better control and treatment of immune-mediated diseases by exploring the universe of 
  microenvironment imposed tissue signatures and their correlates in liquid biopsies

 
Prof. Dr. Reinhard Schneider

 

Goals

The transdisciplinary ImmUniverse consortium aims to advance the diagnosis, management and treatment for ulcerative colitis and atopic dermatitis.

Method

The project studies the role of crosstalk between tissue micro-environment and immune cells in disease progression and response to therapy.

Implementation

By implementing non-invasive liquid-biopsy methodologies combined with circulating biomarker assays, ImmUniverse envisages the replacement of invasive biopsy procedures that make up the current choice in clinical surveillance of immune-mediated diseases.

Where

The expertise and technological support of the ImmUniverse international partnership is complemented by clinical studies across 6 European countries (BE, DE, DK, FR, NL and UK).

Uni.lu role

Uni.lu is responsible for establishing and operating the ImmUniverse virtual biobank platform and the data and analysis portal. Furthermore, Prof. Dr. Schneider’s team is also leading the implementation of ulcerative colitis and atopic dermatitis disease maps while ensuring data security.

Success stories and updates

News ImmUniverse

EU

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 853995 with EU Horizon 2020 EFPIA support.

 
Luxembourg Centre for Systems Biomedicine

 

 
Bioinformatics Core Research Unit

 

 
www.immuniverse.eu

 

 
H2020 – Innovative Medicine Initiative
€ 15 500 000

 

 
01/01/2020 – 31/12/2024

 

  • Humanitas University
  • Austrian Institute Of Technology
  • Istituto Superiore Di Sanita
  • Christian-Albrechts-Universitaet Zu Kiel
  • University Of Cambridge
  • Academisch Medisch Centrum Bij De Universiteit Van Amsterdam
  • Vib Vzw
  • Katholieke Universiteit Leuven
  • Ludwig-Maximilians-Universitaet Muenchen
  • Aarhus Universitet
  • Aarhus Universitetshospital
  • Joanneum Research Forschungsgesellschaft
  • Stichting Katholieke Universiteit
  • Centre Hospitalier Regional Universitaire Nancy
  • IT For Translational Medicine (ITTM SA)
  • Forum Europeen Des Patients
  • European Federation Of Asthma & Allergy Associations
  • European Federation Of Crohn's And Ulcerative Colitis Associations
  • Eurice European Research And Project Office
  • Scuola Superiore Di Studi Universitari E Di Perfezionamento S Anna
  • Glaxosmithkline R&D
  • Sanofi-Aventis Deutschland
  • Eli Lilly And Company Limited
  • Novartis Pharma AG
  • Pfizer Limited

 

cities 2030

 

  Cities2030
  Co-creating resIlient and susTaInable food systEms towardS FOOD2030

 
Prof. Dr. Thomas Engel

 

Goals

41 partners forming the international consortium of Cities2030 work towards transforming and restructuring the way systems produce, transport and supply, recycle and reuse food in the 21st  century.

Method

Build on a “Foot+Tech Connect” approach, the complex holistic system methodology, is citizen-driven and considers all relevant elements, including Social Sciences and Humanities (SSH). The project foresees a set of activities for policy framework development and innovative action which engages and activates all agents of the urban food supply chain, providing thus an undisputable proof of effective urban food systems and ecosystems.

Implementation

Cities2030 puts forward a multiple of tools such as a community of practice (the Cities and Regions Food Systems Alliance) supported by a digital platform, reaching all over Europe and beyond.

Where

The cities of Bremerhaven, Bruges, Haarlem, Iasi, Quart de Poblet, Murska Sobota, Seinajoki, Velika Gorica, Vejle, Vicenza together with the regions of Troodos and Vidzeme will act as front-runners for policy system thinking activities and living labs.

Uni.lu role

Prof. Dr. Engel’s team contributes to the research parts of the project that touch the main focus areas of the SECAN-Lab group, namely research topics like privacy by distribution, network and system security, SCADA and cyber security, Big Data, IoT, vehicular communication and multimodal traffic management, wireless networks and mobile security.

The living lab concept and the project plans are crucial to implement it at policy level as well.

Success stories and updates

News Cities 2030

EU

The project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Grant Agreement No 101000640.

 
Faculty of Science, Technology and Medicine

 

 
Department of Computer Science 

 

 

 

 
H2020 – Societal Challenges
€ 11 779 827,25

 

 

 

  • Universita Ca' Foscari Venezia
  • European Project Consulting
  • Stad Brugge
  • Katholieke Hogeschool Vives Zuid
  • Istanbul Avrupa Arastirmalari Dernegi
  • Inagro
  • Erevnitiko Idrima
  • Razvojna Agencije Grada Velika Gorica
  • Inventivna Rjesenja
  • Vejle Kommune
  • Quantitas
  • Into Seinajoki
  • Proagria Etela-Pohjanmaa
  • Smart & Lean Hub
  • Stadt Bremerhaven
  • Verein Zur Forderung Des Technologietransfers An Der Hochschule Bremerhaven
  • Biozoon
  • Ayuntamiento De Quart De Poblet
  • Fundacion Socialinnolabs

 

 

  MEESST
  MHD Enhanced Entry System for Space Transportation

 
Dr. Jan Thoemel 

 

Goals

MEESST aims to make safe atmospheric (re-)entry at hypersonic flows a reality by implementing the first demonstrator of active magnetic shielding. The project will tackle two associated issues: significant thermal loads on the spacecraft surface and radio communication blackouts.

Method

Beyond accurate models for communication physics, the MEESST consortium will develop a new generation of superconducting magnets that would be effective in manipulating the plasma around a (re)entry space vehicle while be compact and lighter enough to be carry onboard.

Implementation

A dual communication channel – hypersonic fluid dynamics model will be compared with experimental data from the prototype that will be tested in on-ground plasma facilities.

Where

While lab experimental investigations will be taking place in plasma testing facilities in Germany, the manufacturing of the prototype will be a French-German collaboration.

Uni.lu role

The Uni.lu team, led by Dr. Thoemel and Dr. Merlano Duncan, will focus on the modelling of the plasma and the communication channel physics. Furthermore, Uni.lu will lead the efforts of linking these models with other project software and of validating the simulation results against experimental data.  

Success stories and updates

 

EU

The project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Grant Agreement No 899298.

 
Interdisciplinary Centre for Security, Reliability and Trust

 

 
Department of Remote Sensing
Signal Processing and Communications

 

 

 

 
H2020 – Future Emerging Technologies
€ 3 482 057,50

 

 
01/10/2020 – 30/09/2023

 

  • Katholieke Universiteit Leuven
  • Absolut System
  • Universitaet Stuttgart
  • Theva Dunnschichttechnik
  • AEDS
  • Institut Von Karman De Dynamique Des Fluides
  • Neutronstar Systems
  • University Of Southampton
  • Karlsruher Institut Fuer Technologie

 

Admorph

 
  ADMORPH
  Towards Adaptively Morphing Embedded Systems

 

 
Prof. Dr. Marcus Völp 

 

Goals

The ADMORPH project aims to provide an effective solution to system faults and cyber-attacks, for both traditional mission- and safety-critical embedded systems and for their autonomous and networked counterparts: Cyber Physical Systems (of Systems) - CPS(oS).

Method

The project partners will demonstrate fault and intrusion tolerance through a novel, holistic approach for systematically designing, analyzing, and run-time managing embedded computer systems in mission- or safety-critical CPS(oS) that use the concept of system adaptivity in the form of dynamic task-to-resource allocation.

Implementation

The methodologies, methods and tools developed under ADMORPH will be evaluated using radar surveillance systems, autonomous aerospace systems, and urban guided transportation management and control systems domains as industrial use cases.

Where

While the adaptivity technology will be tested via simulated environments in Ireland, the Netherlands and the Czech Republic, the project results and outcomes will be made available to the community at large.

Uni.lu role

Under the guidance of Dr. Völp, Uni.lu leads the efforts on developing the adaptation building blocks (e.g, methods, protocols, tools and techniques) required for an effective CPS(oS) response to extreme, disruptive events (WP2). Furthermore, Uni.lu will disseminate the project results to its PhD candidates through relevant courses, to the general public through outreach events, such as science.lu, and to the affiliated national and international industry.

Success stories and updates

admorph.eu

EU

The project has received funding from the European Union’s Horizon 2020 research and innovation programme under the grant agreement No 871259.

 
Interdisciplinary entre for Security, Reliability and Trust

 

 
Department for Critical and Extreme Security and Dependability Research

 

  
admorph.eu

 

 
H2020 – Industrial Leadership
€ 4 499 468

 

01/01/2020 – 31/12/2022

 

  • Universiteit Van Amsterdam
  • Thales Nederland Bv
  • Sysgo S.A.S
  • Lunds Universitet
  • United Technologies Research Centre Ireland, Limited
  • Q-Media, S.R.O.
  • Fciencias.Id - Associacao Para A Investigacao E Desenvolvimento De Ciencias
  • Universität Augsburg

 

Sinfonia

 
  SinFonia
  Synthetic biology-guided engineering of Pseudomonas putida for biofluorination

 
Prof. Dr. Carole Linster

 

Goals

SinFonia aims to make the long-sought-after goal of producing alternative and safer fluorinated polymers from renewable substrates a reality. This will be achieved by designing sustainable bioprocesses and rewiring the metabolically versatile, non-pathogenic soil bacterium Pseudomonas putida to incorporate inorganic fluorine into its metabolism.

Method

By exploiting the bacterium’s native machinery, SinFonia applies a variety of innovative methodologies (in silico design, genome engineering, adaptive laboratory evolution, bioprocess and advanced metabolic engineering) to generate novel fluoropolymers from an inexpensive and safe salt, sodium fluoride, and sugar.

Implementation

The SinFonia consortium will in the end showcase and assess the industrial applicability of two novel fluoropolymers with varying side chain lengths. The fluorine will provide the polymer with its durability, water and oil-repellency, thermostability, and conductivity properties, while side chain length will determine properties like its hardness, cross-linkability, and flexibility. The fluoropolymers are anticipated to be utilized in self-cleaning surfaces, low-surface-energy coatings, bio-based lubricants, membranes for fuel cells, and anti-fouling materials.

Where

With a partnership formed out of 3 research organizations, 4 academic institutions, 1 large industry and 5 SMEs from 10 European countries, the SinFonia consortium covers not only the required scientific experts but also the entire chain to produce, characterize, and bring the novel fluoropolymers to market. Experimental, industrial testing and scale-up activities will take place in France, Estonia, UK, Ireland and the Netherlands.

Uni.lu role

Dr. Linster’s research group will lead the metabolic profiling and metabolite repair-based strain optimization efforts. Additionally, expert advice on unknown compound identification (e.g. fluorometabolites) from mass spectral data will be provided by the Environmental Cheminformatics group of Uni.lu.

Success stories and updates

 

EU

The project has received funding from the European Union’s Horizon 2020 research and innovation programme under the grant agreement No 814418.

 
Luxembourg Centre for Systems Biomedicine

 

Enzymology and Metabolism
Environmental Cheminformatics

 

  
www.sinfoniabiotec.eu

 

 
H2020 – Industrial Leadership
€ 7 948 503, 48

 

 
01/01/2019 – 28/02/2023

 

  • Danmarks Tekniske Universitet
  • Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Ev
  • Masarykova Univerzita
  • The University Court Of The University Of St Andrews
  • Agencia Estatal Consejo Superior De Investigaciones Cientificas
  • Tartu Ulikool
  • Bioplastech Ltd
  • Biofaction Kg
  • Altar
  • In Srl
  • Institut Fur Energie Und Umweltforschung Heidelberg Gmbh
  • Chemours Netherlands Bv

 

 
  CONNECT
  Connecting neural networks: Nervous-system-on-Chip Technology

 
Prof. Dr. Jens Schwamborn

 

Goals

The CONNECT project aims to enable the study of a complete organ system, including the connectivity of the nervous system in view of improving predictions about the onset of Neurodegenerative Diseases (NDDs) and consequently the development of personalized treatment concepts.

Method

The project consortium will model the functioning of the human nervous systems in a chip-based in vitro model using state-of-the-art stem cell technology, nanofabrication and tissue engineering.

Implementation

The artificial platform developed under the CONNECT project will be tested using working hypotheses for the evolution and functioning of the Parkinson’s disease, the second most common NDD.

Where

The strongly complementary of the 7 European partners is demonstrated by the specific expertise brought to the CONNECT project: tissue engineering (Luxembourg), stem cell biology (UK), microfluidics (Finland), nanofabrication and translational neurobiology (the Netherlands) and advanced imaging (Belgium).

Uni.lu role

Dr. Schwamborn’s team will lead the efforts associated with the generation of midbrains/hindbrains bringing in extensive expertise in human stem cells differentiation, the generation of brain organoids and the detection of disease specific phenotypes in the respective in vitro systems.

Success stories and updates

fet-proactive-connect.com/news

EU

The project has received funding from the European Union’s Horizon 2020 research and innovation programme under the grant agreement No 824070.

 
Luxembourg Centre for Systems Biomedicine

 

 
Developmental and Cellular Biology 

 

 
fet-proactive-connect.com

 

 
H2020 – Future and Emerging Technologies
€ 6 807 867,50

 

 
01/01/2019 – 31/12/2023

 

  • Technische Universiteit Eindhoven
  • The University Of Sheffield
  • Aalto Korkeakoulusaatio
  • Katholieke Universiteit Leuven
  • Erasmus Universitair Medisch Centrum Rotterdam
  • Ffund Bv